Page 10 - Randomised Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oxford University's COVID-19 therapeutics trial goes global ANI | Updated: Feb 18, 2021 17:57 IST London [UK], February 18 (ANI): A UK trial of potential Covid-19 treatments has started to enroll patients in other countries in the hope of speeding up results, Oxford University said on Thursday. CNN reported that The RECOVERY trial looks at whether existing drugs can be used to treat the virus. The trial has enrolled more than 36,000 hospital patients in the UK since March 2020 and is now expanding to countries including Indonesia and Nepal. "The Randomise...

India set for funding wave with flurry of IPOs in 2021 Amazon and Flipkart make up 80% of India’s e-comm market sharePremium 2 min read Share Via Read Full Story India’s internet economy is set to attract massive investments as several players such as food-delivery startup Zomato, courier service provider Delhivery, Walmart-owned Flipkart, and e-tailer Nykaa are expected to enter the public market in 2021. “More than $60 billion has been invested in India’s internet startups in the past five years, with around $12 billion in 2020 alone. Many of these leaders, which operate businesses ...

Researchers may have pinpointed a new treatment method for the coronavirus. A new study says this arthritis medication could prevent you dying from COVID.

email article Tocilizumab (Actemra) showed a slight but statistically significant mortality benefit in critically ill COVID-19 patients, according to a press release from the U.K.'s pragmatic RECOVERY trial. Of patients treated with tocilizumab, an IL-6 inhibitor used for rheumatoid arthritis and related conditions, 29% died within 28 days versus 33% of patients treated with usual care (rate ratio 0.86, 95% CI 0.77-0.96, P 0.007), researchers stated. This amounted to a number needed to treat of 25 to save one additional life. And tocilizumab improved the probability of "discharge alive...

Tocilizumab appears to reduce the risk of death in hospitalized patients with severe Covid-19, researchers at the University of Oxford said